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Abstract
Introduction—Transitioning from adolescence to adulthood can be problematic for individuals 
with rare disabilities such as muscular dystrophy (MD).
Methods—We identified a cohort of 220 individuals with MD and 440 matched comparison 
individuals and measured emergency room (ER) and inpatient (IP) encounters for the years 2000 
through 2010, using all-payer hospital discharge uniform billing data. We compared ER and IP 
use rates for people with and without MD, and for 15 - 19 year-olds with MD to 20 - 24 year-olds 
with MD.
Results—ER and IP use rates were significantly higher among individuals with MD than in the 
comparison group. Additionally, ER and IP use rates were significantly higher in the 20-24 year 
age group than in 15-19 year-olds.
Discussion—Additional research is needed to examine whether increased ER and IP use in 
young adults is attributable to difficulties in healthcare transition versus increased disease severity.
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Introduction
Muscular dystrophies (MDs) are a group of heterogeneous conditions characterized by 
progressive muscle weakness and dystrophic changes identified through muscle biopsy.1 
The age of onset for the various types of MDs ranges from infancy to later adulthood and 
can affect multiple body systems. For childhood-onset MDs such as Duchenne and 
congenital muscular dystrophies, respiratory and cardiac issues have been the cause of 
significant morbidity and early mortality; however, multidisciplinary care and interventions 
such as ventilator use have led to increased survival into adulthood.2-6
Improvement in survival of children with MDs has highlighted the need for successful 
transition from pediatric to adult health care. The goal of transition is to ensure that 
individuals receive age-appropriate health care services that maximize functioning and 
prevent adverse health outcomes.8-12 Transitioning a young adult from pediatric services 
also demonstrates that there is a realistic expectation of living into adulthood and enhances 
the individual's sense of responsibility and self-esteem.13,14 However, numerous barriers 
inhibit a smooth transition including: lack of pediatric provider support in planning, patient 
and caregiver apprehension of the different approaches of pediatric and adult providers, 
failure to involve young people in planning, and a lack of adult providers with adequate 
training.8,12,14-23
Studies have shown higher rates of emergency room (ER) use and hospitalizations for young 
adults with special healthcare needs.15, 24 However, research on healthcare use surrounding 
the period of transition for individuals with MD is limited. Only 1 study has examined 
healthcare use patterns among children and young adults with MDs.25 Ouyang et al 
measured healthcare use and expenditures in patients with MD through a private insurance 
database and found that children with MDs have higher use and expenditures than children 
with other special healthcare needs. Additionally, they reported that use and expenditures for 
15-19 year olds was higher when compared with adults age 20-24; however, as the 
percentage of females was higher in the adult group, they postulated that the older age group 
likely included people with less severe adult-onset MDs who would be more likely to be 
employed and thereby have better access to private insurance and have lower healthcare use 
than those with more severe MD.25 Analyzing data from private and public payers would 
allow comparisons to be drawn between similar adolescent and adult MD groups to 
understand healthcare use during the transition period.
Using data from South Carolina Medicaid, State Employee Health plan, and Hospital 
Discharge Uniform Billing, the purpose of this study was to: 1) compare the rates of ER and 
inpatient (IP) hospital use for individuals with MD and matched controls without MD age 15 
to 24 years old, when transition to adult medical care is likely to occur; and 2) to analyze 
rates of ER and IP hospitalizations among individuals with MD by age and other socio-
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demographic attributes. We hypothesized that young adults (age 20-24 years) with MD 
would have higher rates of ER and IP use than adolescents with MD (age 15-19 years), due 
to a combination of worsening health for people with Duchenne MD or Becker MD (DMD; 
BMD) as well as challenges involved with transition to adult health care providers.
Materials and Methods
Study Design and Setting
We conducted a retrospective cohort study using administrative data in South Carolina to 
describe ER and IP hospital use among people with MD, from ages 15 - 24, and to 
investigate the association between age (as a proxy for transition from adolescence to 
adulthood) and use. This study is part of a larger project investigating the transition from 
pediatric to adult services for adolescents and young adults with rare health conditions. The 
study protocol was approved by the South Carolina Department of Health and Human 
Services, the South Carolina Employee Benefit Administration, the South Carolina Data 
Oversight Council, the South Carolina Department of Health and Environmental Control, 
and the South Carolina Department of Social Services and was granted exempt status by the 
institutional review board at the University of South Carolina.
Data Sources
A cohort was identified from Medicaid, the South Carolina State Employee Health Plan 
(SHP), and all-payer hospital discharge uniform billing (UB) data. Medicaid is a state-run 
health insurance program for people with low income; children and adolescents can qualify 
on the basis of income alone, and individuals under age 18 years with significant disability 
are eligible regardless of family income. Adults younger than 65 are typically eligible for 
South Carolina Medicaid only if they have a low income in addition to a significant 
disability. Individuals who qualify as children because of a disability can remain enrolled in 
Medicaid if their individual income remains low and if the severity of the disability is 
sufficient (criteria for disability benefits are not always the same for children and adults with 
the same condition). The SHP is a self-insured plan, managed by SC Blue Cross/Blue 
Shield, which includes government workers from all sectors. The UB data includes IP and 
emergency department discharge billing data extracted from all general, short-term acute 
care hospitals within the state. These data systems are housed at the South Carolina Revenue 
and Fiscal Affairs Office, Health and Demographics Section (H&D), the central repository 
of the state's health and human service data. To “link across” data sources from multiple 
providers, H&D developed a series of algorithms using source-specific personal identifiers 
to create a global unique identifier. Using the global identifier in lieu of personal identifiers 
enables staff to create views of data across multiple providers while protecting 
confidentiality. This identifier can be unduplicated across data systems to avoid over-
counting of individuals. Case and comparison group unique identifiers were linked to vital 
records for years 2000-2011 to determine if anyone died from any cause.
Cohort Identification
To be included in the study, individuals were aged between 15 - 24 years for at least 1 year 
during the 2000 through 2010 time frame. They also were enrolled in the South Carolina 
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Medicaid program or State Health Plan for at least 1 calendar year during the study period. 
MD cases were identified from these data sources based on diagnosis with 1 of 3 ICD-9 
codes for MD (359.0, 359.1, and 359.21) on at least 2 occasions. For the 2000-2010 study 
period 220 unique cases of MD were identified. Participants were followed for ER and IP 
use during the study period until 1 of the following endpoints:
• The end of 2010;
• Attainment of age 25;
• Death
The denominator included person-years, which were calculated as the sum of all the number 
of years under observation across all of the persons.
Comparison Group
We created a comparison group, matched on age, gender, and years of insurance coverage, 
of people from the SHP. We calculated a propensity score based on age, gender, and years 
of insurance coverage and randomly selected 2 people for each case for comparisons based 
on propensity score. If 2 people with identical scores could not be identified, an individual 
with the next closest absolute difference score was identified. We identified 440 unique 
comparison individuals for our MD cases from the SHP. We excluded from the comparison 
group people who had spina bifida (741), cerebral palsy (343), spinal cord injury (344.0, 
344.1, 767.4, 806, 952, 907.2), intellectual disability (317-319), fragile X syndrome 
(759.83), autism spectrum disorders (299), or multiple sclerosis (340). This was not intended 
to be an exhaustive list of exclusions but was done to make the comparison group a 
relatively “healthy” group rather than comparing adolescents and young adults with MD to 
those with other significant disabilities.
Outcome Variables (Use)
ER and IP hospital use was ascertained for everyone in the case and comparison cohort 
using uniform billing (UB) data for all civilian hospitals located in South Carolina. UB data 
included the date of service and the primary ICD-9-CM codes for ER and IP 
hospitalizations. UB data were utilized to capture events that could have occurred when a 
case or comparison had lost insurance during our study period.
We examined ER visits and IP hospitalizations to evaluate use for any cause, by specific 
body system conditions (categorized using ICD-9 codes), and Ambulatory Care Sensitive 
Conditions (ACSC). ACSC are conditions that should be manageable in the outpatient 
setting, and therefore ER visits or hospitalizations for them would represent a failure or 
unmet need in terms of the receipt of primary care. ACSC may be particularly relevant for 
people with MD because: (a) some of the conditions that comprise ACSC (such as bacterial 
pneumonia) are conditions for which people with MD are at increased risk and (b) an 
increase in ER and IP use for ACSC as individuals go from adolescence to adulthood could 
serve as a marker for difficulty in successfully transitioning from pediatric to adult medical 
care. ACSC were identified and categorized using a data tool developed by the Agency for 
Healthcare Research and Quality for monitoring the health care safety net using 
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administrative data (see Supplementary Table S1, available online).26 We supplemented the 
original data tool by adding additional codes from the AHRQ prevention quality indicator 
measures.27 We also included incidence rates of ER and IP use according to different body 
systems using ICD-9-CM book chapter groupings (see Supplementary Table S2, available 
online); these groupings use all encounter data and are not limited to ACSC.
Use rates were calculated in terms of person years. We calculated a total rate that includes 
both ER visits and IP hospitalizations. We also analyzed separately ER visits and 
hospitalizations. In addition to comparing MD rates to the comparison group rates, we were 
also interested in the potential impact of age on use rates. Because care transition from 
pediatric to adult care is expected to occur in the late teen years, we elected to dichotomize 
age into less than 20 (ages 15 - 19 years) and 20 or older (20 - 24). For each condition, we 
compared the use rates for the younger group to the older group.
Other Data
Other variables analyzed included gender, race, and county of residence (classified into 
urban and rural). The county of residence was categorized as urban or rural using 2010 
Rural Urban Commuting Area (RUCA) Codes. Information on socioeconomic status (SES) 
was obtained from the South Carolina Department of Social Services Supplemental 
Nutrition Assistance (formerly food stamps) Program (SNAP); eligibility for this program is 
dependent on being at or below the federal poverty level and was used as a surrogate marker 
for SES.
Statistical Analyses
Inference on Generalized estimating equation (GEE) models28 assessed differences between 
the MD group and the comparison group. The motivation for estimating GEE models was 
the presence of repeated observations from the same individuals during the study period. 
The GEE approach extends generalized linear models to account for within-group correlated 
data; in our case, this approach accounts for repeated (correlated) observations from the 
same person. The GEE model was estimated by specifying REPEATED statement in the 
GENMOD procedure of SAS 9.3 (SAS Institute Inc., Cary, NC). Each regression model 
included MD versus comparison group as the key independent variable and assumed a 
Poisson distribution relationship between the mean and variance for the dependent variables 
of ER and IP use. We specified the log link function so that incidence rate ratios (IRR) could 
be calculated as exponentiated regression coefficients. Separate models were run for ER and 
IP use for any cause, for ACSC, and for each body system listed in the ICD- 9 CM. In each 
Poisson model, we controlled for age group, gender, race, urban or rural county of residence, 
and SNAP enrollment as a marker for socioeconomic status. We were unable to control for 
race in the initial models, because the State Health Plan does not include a race variable. 
However, when we limited the models to individuals with MD to assess the role of age and 
other characteristics specifically in this group, we were able to control for race in those 
models. All variables were assessed using Wald tests based on the empirical standard errors 
so that inference is robust to misspecification of the within-person correlation structure 
which was assumed to be exchangeable in our models. Statistical significance was based on 
a 2-sided p-value of 0.05.
Mann et al. Page 5
Muscle Nerve. Author manuscript; available in PMC 2016 November 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
We then stratified each model by limiting to only MD and re-estimated the models with age 
group as the key independent variable, controlling for the same covariates as before with the 
addition of race. To ensure adequate sample sizes, we only estimated models for which there 
were at least 50 observations available. We also tested the effect of stratifying the models, 
first limiting them only to individuals found to have data during both age ranges (15 - 19 and 
20 -24); this was done in order to better evaluate the association between age and use, while 
minimizing bias due to potentially different characteristics for individuals who were present 
during only 1 age range. Then we limited the modeling to males, since many types of MD 
affecting individuals in the age groups being studied (including Duchenne and Becker MD) 
are transmitted via an x-linked recessive pattern and are, therefore, much more prevalent in 
males.
Results
Descriptive Information
Descriptive information on the MD cohort and the comparison group is shown in Table 1. 
There were 220 people with MD, and the comparison group included 440 people. As would 
be expected, a majority of the sample was male. The MD and comparison group were 
similar on most characteristics, except that race is not available in the SHP data and was 
therefore missing for the comparison group. Only 10% of the MD group and 3.4% of the 
comparison received SNAP benefits at any time during the study period.
Use Rates, Full Cohort
There were 871 person-years of follow-up for people with MD in the 15-19 year age range 
and 640 person-years for people with MD in the 20-24 age range. Among the comparison 
group there were 1,733 and 1,393 person-years in the 2 age ranges, respectively. Unadjusted 
rates of IP and ER use, by demographic and other characteristics, are available in the 
supplemental online tables (Supplementary Table S3). Compared with the comparison 
group, people with MD had significantly higher adjusted rates of total ER [incidence rate 
ratio (IRR) = 2.77, P < .01] and IP (IRR = 10.92, P < .01) use and ER (IRR = 3.48, P < .01) 
and IP (IRR = 66.58, P < .01) use due to any ACSC. Adjusted rates were especially elevated 
in people with MD for IP use specifically for the ACSC of bacterial pneumonia (IRR = 
113.38, P < .01) and for IP use for respiratory conditions (IRR = 120.40, P < .01). People in 
the 20-24 age range had significantly higher rates of total ER (IRR = 1.54, P < .01) and IP 
(IRR = 1.64, P = .01) use and higher rates of ER use (IRR = 1.72, P < .01) for ACSC but not 
IP (IRR = 1.31, P = .33) use for ACSC. Full results for the models that included both people 
with and without MD are available from the authors upon request.
Use Rates among People with MD (Table 2)
When modeling ER and IP use only among individuals with MD, older age (20-24) was 
associated with significantly increased rates of overall ER and IP use and with ER use for 
any ACSC. IP use for ACSC did not differ significantly by age. Small cell sizes did not 
permit examination of the association between age group and ACSC use for any condition 
other than IP admission for bacterial pneumonia, which did not differ significantly by age 
group. Significantly greater ER use was found among 20-24 year old individuals for the 
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following types of conditions: digestive, musculoskeletal, respiratory, and ill-defined. No 
significant differences in IP admission rates were detected for any body system.
There was significantly less IP use for any respiratory condition among individuals who 
were not white. SNAP use was associated with significantly increased ER use overall and 
for ACSC, but not for IP use. Specifically, people enrolled in SNAP were significantly more 
likely to use ER services for any digestive condition or for any respiratory condition. 
Females experienced higher rates of ER use overall and for ACSC but did not have higher 
rates of IP use. In fact, the rates of IP use for any ACSC and for the ACSC of bacterial 
pneumonia were significantly lower in females than in males. By body system, females were 
significantly more likely to use ER services due to any genitourinary condition or any 
musculoskeletal condition and significantly less likely to experience IP admission due to any 
respiratory condition.
Use Rates among People with MD, Present in both the 15-19 and 20-24 age ranges (Table 
3)
There were 152 individuals (105 males) with MD who were present in the data for at least 1 
year between the ages of 15 and 19 and for 1 year between the ages of 20 and 24. There 
were 678 person-years of follow-up in the 15-19 year age range and 604 person-years in the 
20-24 year age range. The associations between age and use were similar to those shown in 
Table 2, though in some cases the association was stronger. In addition, although there was 
not a significant association between age group and IP use for ACSC in the entire cohort 
with MD, this association was significant for individuals who were present in the data 
during both age periods.
Use Rates among Males with MD, Present in both the 15-19 and 20-24 age ranges (Table 4)
Among the 105 males with MD who were present in the data for at least 1 year between the 
ages of 15 and 19 and for 1 year between the ages of 20 and 24, there were 479 person-years 
of follow up in the 15-19 year age range and 392 person-years in the 20-24 year age range. 
The association between age and use was found to be very similar to that shown in Table 3.
Discussion
As anticipated, we found that individuals with MD had a higher rate of ER and IP use than 
those in the comparison group. The increased rates of use in the older age group of 
individuals with MD may indicate difficulties with access to and quality of adult ambulatory 
health care, though increasing severity of disability with age (especially for boys and men 
with DMD or BMD) probably contributes substantially as well. We did not find significant 
associations between rural/urban county or race and overall or ACSC ER or IP use in 
general, though there was a significantly lower rate of IP use for any respiratory condition 
for people with black or other race compared to whites. It is difficult to speculate on the 
cause of this difference, which was highly significant (P = .002). Overall and ACSC ER use 
was increased significantly for individuals who had ever been enrolled in the Supplemental 
Nutrition Assistance Program (a marker of lower SES). Evidence from population-based 
research shows that low income is associated with increased ER use, even when controlling 
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for insurance status and demographic characteristics.29 The reasons for this association are 
not known but may apply to people with MD as well as to the general population.
Girls and women had higher rates of overall ER use but did not have a higher rate of overall 
IP use. For ACSC, the rate of ER use was similarly elevated, but the rate of IP admission 
was significantly lower than for males. Females with MD were far more likely to have ER 
visits due to genitourinary conditions, whereas males were substantially more likely to be 
hospitalized for respiratory conditions. The increased rate of ER use for genitourinary 
conditions in females with MD likely reflects differences in anatomic susceptibility to 
genitourinary conditions that is not related to MD. On the other hand, the increased rate of 
hospitalization for respiratory conditions in males with MD may reflect the increased risk of 
pulmonary insufficiency for individuals with Duchenne or Becker MD as they age. When 
we restricted the models to individuals with MD who were also present in both the 15-19 
year old and 20-24 year old time frames, the findings changed little, though a significant 
elevation in the rate of IP use for any ACSC increased. This likely represents the effects of 
ensuring that the individuals included in the age group comparison represented the same 
types of MD, resulting in a “cleaner” comparison with greater power to detect the 
difference. Again, we hypothesize that some of this difference may be explained by the 
effects of health care transition, but increasing severity of limitations due to MD is also an 
important factor.
This study has several limitations. First, we rely on administrative data for all the diagnoses 
studied, including MD. Since we do not have access to clinical data, it is possible that some 
of the diagnoses of MD or of reasons for ER or IP use are erroneous (e.g., misdiagnoses or 
errors in selection of billing codes). We attempted to minimize errors in the diagnosis of MD 
by restricting cases of MD to individuals who had 2 or more muscular dystrophy codes, but 
it is possible that some members of the MD group actually do not have MD, and some of the 
reasons for ER and IP use may have been mischaracterized. In general, such errors would be 
expected to be non-differential and therefore are likely to bias the results toward the null 
rather than toward finding erroneous associations. A more significant limitation due to our 
reliance on billing codes is our inability to distinguish specific types of MD through the use 
of ICD-9 codes, as 1 code can specify more than 1 type of MD. Ideally, the 3 codes would 
permit some degree of differentiation among the MD types; however, an exploratory 
analysis of the data revealed that most of the individuals diagnosed with MD were 
diagnosed using at least 2 different ICD-9 codes at various times during the study period 
(data available upon request). Confounding by type of MD should not be a significant 
problem for our analyses of age in the models limited to individuals present during both time 
periods. However, the findings of this study represent the “average” effect of age in people 
with MD, and study data cannot detect differences in use by age by type of MD.
Third, there are limitations related to the selection of an appropriate comparison group for 
individuals with MD. Since a comparison group drawn from Medicaid is likely to include a 
large proportion of individuals with disabilities (in the adult age groups), we selected a 
largely healthy comparison group from the SHP to avoid drawing erroneous conclusions by 
comparing individuals with MD to people with other (but unidentified) disabilities. 
However, this means the comparison and MD groups may not be comparable in terms of 
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socioeconomic and demographic factors. We attempted to account for differences in SES by 
controlling for SNAP enrollment.
Fourth, while we used commonly accepted definitions for ACSC, it must be acknowledged 
that some conditions which are ambulatory care sensitive in the general population may not 
be as amenable to outpatient treatment in people with MD, especially those with more 
severe disease. It is probably incorrect to assume that all ambulatory care sensitive ER and 
IP use in people with MD would be preventable via improved ambulatory care.
Finally, while we adjusted for confounding to the degree possible, we were unable to control 
for all potential confounders. For example, as described above, we used an indicator variable 
for whether an individual was ever enrolled in the Supplemental Nutrition Assistance 
Program as a proxy for socioeconomic status; while this variable was a significant predictor 
in many of our models, it is an imperfect indicator of SES. Race information was available 
only for individuals enrolled in Medicaid, as the State Health Plan does not collect 
information on race. For this reason we could not include race as a covariate in our initial 
models comparing IP and ER use of individuals with MD to the comparison group from the 
SHP. However we were able to obtain race information for all individuals with MD, as most 
were enrolled in Medicaid or had encounters of other types, such as hospital admissions, so 
we controlled for race in the models limited to people with MD.
All the analyses conducted in this study were pre-planned, so we did not adjust P-values for 
multiple comparisons. It might be argued that adjustment is needed for the secondary 
outcomes (in this case the specific types of IP/ER use). For Table 2, Bonferroni adjustment 
would reduce the P-value needed for statistical significance to 0.0083 or below. If we 
applied this criterion to the condition-specific associations between age group and IP/ER 
use, 9 of the 10 statistically significant associations would remain significant. For Table 3, 
the P-value required for significance would be 0.010 or below, and 8 of the 12 significant 
associations with age would remain significant. For Table 4, the required P-value would be 
0.017, and all 4 significant associations with age would remain significant.
This study has several strengths. The greatest strength is the ability to use linked data across 
multiple sources to identify a large cohort of individuals with MD and describe their ER and 
IP use experiences over time. MD is a rare condition, so it is difficult to conduct sufficiently 
powered research related to it. Using South Carolina's advanced system of data linkage, we 
were able to identify 220 people with MD and include them in the study. We found a 
number of statistically significant associations, which is a testimony to the adequacy of the 
sample size for the study. The linked data system also permits controlling for a number of 
important variables, including SNAP enrollment as a proxy for SES and the rural/urban 
county of residence. We used “uniform billing” (UB: hospital and ER) data for all analyses. 
UB data are provided from all public, private, specialty, and general hospitals in South 
Carolina, so they provide a comprehensive picture of hospital use (not including Veterans 
Administration hospitals). We decided to use UB data because an individual's enrollment in 
Medicaid or the State Health Plan is not necessarily constant. Only relying on these data 
sources could result in important information being missed or in biased findings, since 
people may “save up” their health care use for time periods in which they have insurance 
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coverage. The strength of the uniform billing data is that they include all hospitalizations in 
the state regardless of insurance status or payer. A limitation is that they only include 
hospitalizations/ER visits within the state; if a resident of South Carolina received care 
outside the state (for example, in a border city such as Charlotte, NC) that information 
would not be available.
In summary, 15-24 year old individuals with MD living in South Carolina have increased 
rates of overall and ACSC-related ER and IP use compared to individuals of the same age 
without MD. Among those with MD, increased age (20-24 versus 15-19 years) is associated 
with increased IP and ER use, and race and gender also appear to be related to patterns of 
use. These results identify potential opportunities for intervention to improve the healthcare 
access of people with MDs by highlighting health conditions that could be managed better 
through outpatient care. Additional research is needed to investigate the role of transition 
from adolescent to adult health care, versus increasing severity of MD, as a potential cause 
of the increase in ER and IP use as people with MD move from adolescence to adulthood. 
Additional research is also needed to investigate the role of MD type and to clarify the 
impact of race and gender. Finally, we did not address health care expenditures in these 
analyses; further study of predictors of health care expenditures in adolescents and young 
adults with MD are likely to be beneficial from a health policy perspective.
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Table 1
Distribution of the number of adolescents and young adults from South Carolina 
according to condition and demographic and socioeconomic characteristics (2000 – 2010)
Muscular Dystrophy Comparison Group1
Total2 220 440
Gender
 Male 151 (68.6%) 302 (68.6%)
 Female 69 (31.4%) 138 (31.1%)
Age group3
 15 – 19 years 211 (56.7%) 421 (55.3%)
 20 – 24 years 161 (43.3%) 340 (44.7%)
Race
 White 132 (60.0%)
 African American 48 (21.8%)
 Other/Missing 40 (18.2%) 440 (100.0%)
County Description
 Urban 176 (80.0%) 335 (73.1%)
 Rural 44 (20.0%) 105 (23.9%)
Food stamps
 Yes 22 (10.0%) 15 (3.4%)
 No 198 (90.0%) 425 (96.6%)
Eligibility
 Average Number (SD) of Years4 4.1 ± 2.8 4.1 ± 2.8
1Comparison group selected from State Health Plan records, which did not record race. Cases were matched on sex, age and years of insurance 
coverage using propensity scoring.
2
Total = unduplicated number of persons with muscular dystrophy in Medicaid, State Health Plan, and hospital discharge uniform-billing data and 
met study definition criteria.
3Age groups sum to a number greater than overall total. Age category numbers are based on number of persons in each age group. Therefore, 
individuals could be in both age categories.
4
During 2000-2010 study period.
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